| 11:00–11:15 |
For whom? When? Neoadjuvant therapy
Ozan Yazici (Gazi University, Ankara, Turkiye)
|
| 11:15–11:30 |
Fundamental principles of radiotherapy in lung cancer
Ulviyye Nebizade (National Oncology Centre, Baku, Azerbaijan)
|
| 11:30–11:45 |
NSCLC: Surgical aspects of personalised treatment
Mukash Beyshembaev (National Oncology & Haematology Centre, Bishkek, Kyrgyzstan)
|
| 11:45–12:00 |
MDT
Early-stage multidisciplinary case discussion
Case presenter: Bahattin Engin Kaya (Necmettin Erbakan University, Konya)
Sedi Sariyev (AZ) · Serdar Karakaya (TR) · Mustafa Karaca (TR) · Mukash Beishenbaev (KG) · Abdugaffor Rasulov (UZ) · Lazzat Khashimova (KZ)
|
| 14:00–14:15 |
Treatment management — driver-mutation-positive patients
Narmin Memmedova (National Oncology Centre, Baku, Azerbaijan)
|
| 14:15–14:30 |
Treatment management — driver-mutation-negative patients
Rabiga Kadyrbayeva (KazORIR, Almaty, Kazakhstan)
|
| 14:30–14:45 |
Small-cell lung cancer treatment management
Murat Akyol (Bakircay University, Izmir, Turkiye)
|
| 14:45–15:15 |
MDT
Case discussion
Case presenter: Ali Topkac (Dr. Abdurrahman Yurtaslan Oncology Hospital, Ankara)
Ali Dzaraxmat Rzayev (AZ) · Emrah Eraslan (TR) · Temirbek Djumanazarov (UZ) · Rakhim Abdurassulov (KZ)
|
| 15:30–16:00 |
Clinical research experience in Turkiye
Mahmut Gumus (Medeniyet University, Istanbul, Turkiye)
|
| 16:00–16:30 |
Clinical research experience in Kazakhstan
Innara Turkpenova (KazORIR, Almaty, Kazakhstan)
|
| 16:30–16:35 |
Deep inspiration breath-hold technique in stage III NSCLC radiotherapy: dosimetric benefits for organs at risk
Nigar Aliyeva (Azerbaijan)
|
| 16:35–16:40 |
First experience with endoscopic vacuum therapy for anastomotic insufficiency after gastric resections and gastrectomies in oncological patients
Otajanov D.M. (Uzbekistan)
|
| 16:40–16:45 |
Germline variant spectrum in hereditary breast cancer: a whole-exome sequencing study from Azerbaijan (2023–2026)
Arzu Guliyeva (Azerbaijan)
|
| 16:45–16:50 |
Immune system characteristics in ovarian cancer patients receiving immunotherapy
Nabiyeva D.U. (Uzbekistan)
|
| 16:50–16:55 |
Uterine myoma as a potential risk factor in endometrial carcinogenesis
Samira Safarova (Azerbaijan)
|
| 16:55–17:00 |
Immediate results of external beam radiotherapy for bone metastases from various malignant tumours
Aralbaev R.T. (Kyrgyzstan)
|
| 17:00–17:05 |
Evaluation of early clinical efficacy of fast-track protocols in female reproductive system tumours
Muminov B.S. (Uzbekistan)
|
| 17:05–17:10 |
Antiperistaltic intracorporeal anastomosis after laparoscopic right hemicolectomy — better or more cost-effective?
Madyarov J.M., Rasulov A.O. (Russia)
|
| 17:10–17:15 |
Neoadjuvant polychemotherapy in locally advanced breast cancer: an evaluation of therapeutic possibilities
Aliev D.A., Nadjafov T.A. et al. (Azerbaijan)
|
| 17:15–17:20 |
Pathomorphological assessment of targeted therapy efficacy in giant cell tumour of long bones
Umijon Qosimov (Uzbekistan)
|
| 17:20–17:25 |
CA 15-3 as a predictive marker of breast cancer in the male population of Azerbaijan
Aliyeva N.Kh., Aslanova E.F. (Azerbaijan)
|
| 17:25–17:30 |
Treatment sequencing in malignant melanoma with widespread visceral and bone metastases
Basır Hasan, Oğul Ali (Türkiye)
|
| 17:30–17:35 |
Clinico-morphological role of Ki-67 in soft tissue sarcoma prognostication
Tamara Guliyeva (Azerbaijan)
|
| 17:35–17:40 |
Neoadjuvant chemotherapy in hormone receptor–positive breast cancer
Ömer Faruk Elçiçek, Okan Avcı (Türkiye)
|
| 17:40–17:45 |
Optimization of chronic myeloid leukaemia management in Kyrgyzstan
Jusupova Sh.K. (Kyrgyzstan)
|
| 17:45–17:50 |
Vaginal microbiome and HPV 16/18 progression: clinical significance of dysbiosis and statistical correlations
Türkan Mansurova (Azerbaijan)
|
| 17:50–17:55 |
Association of human papillomavirus with precancerous cervical pathologies
Toktonalieva A.N. (Kyrgyzstan)
|
| 11:00–11:15 |
Intra-arterial chemotherapy (TACE)
Davran Isametov (Shymkent, Kazakhstan)
|
| 11:15–11:30 |
Surgical treatment of gastric cancer: Kyrgyzstan experience
Mukhamedali Matkalykov (Bishkek, Kyrgyzstan)
|
| 11:30–11:45 |
Laparoscopic Whipple procedure
Qurbankhan Muslumov (Azerbaijan Min. Invasive Surgery Assoc., Baku)
|
| 11:45–12:00 |
RANKL inhibitor in bone tumours
Bektur Borboldoev (Bishkek, Kyrgyzstan)
|
| 12:00–12:15 |
Anastomotic leak after sphincter-sparing rectal resection and impact of radiotherapy on long-term quality of life
Vugar Yagublu (Heidelberg University, Germany)
|
| 12:15–12:30 |
AstraZeneca — Lynparza (Olaparib)
Sergei Kamyshov
|
| 12:30–12:45 |
Siemens — Varian AI-Powered Solutions
Alexandra Kuznetsova
|
| 12:45–13:00 |
From Risk to Reliability: Centralized Chemotherapy Units Supported by Smart Technologies
Yusuf Ertür (Kapsam)
|
| 14:00–14:15 |
Fundamental surgical principles in breast cancer
Xatun Salmanova (National Oncology Centre, Baku, Azerbaijan)
|
| 14:15–14:30 |
Fundamental principles of radiotherapy in breast cancer
Akmaral Savkhatova (Almaty, Kazakhstan)
|
| 14:30–14:45 |
Current approaches in neoadjuvant therapy
Serkan Yildirim (Selcuk University, Konya, Turkiye)
|
| 14:45–15:15 |
MDT
Early-stage MDT case discussion
Case presenter: Ahmet Kursad Disli (Erciyes University, Kayseri)
Kemale Aliyeva (AZ) · Hacer Demir (TR) · Lola Zakirova (UZ) · Akmaral Savkhatova (KZ) · Almaz Abdyldabekov (KG)
|
| 15:30–15:45 |
Current developments in luminal disease
Yesim Yildirim (Anadolu Medical Centre, Istanbul, Turkiye)
|
| 15:45–16:00 |
Current developments in HER2(+) disease
Sürəyya İmanova (Azerbaijan Medical University, Baku)
|
| 16:00–16:15 |
Current developments in triple-negative breast cancer
Fatma Yalcin Musri (Medical Point, Batman, Turkiye)
|
| 16:15–16:30 |
Molecular subtypes of breast cancer: five-year retrospective analysis
Almaz Abdyldabekov (Bishkek, Kyrgyzstan)
|
| 16:30–17:00 |
MDT
Case discussion
Case presenter: Harun Muglu (Medipol University, Istanbul)
Cavid Geribov (AZ) · Naziye Ak (TR) · Shahnoza Niyazova (UZ) · Akmaral Savkhatova (KZ) · Almaz Abdyldabekov (KG)
|
| 11:00–11:10 | Multidisciplinary approach to diagnosis, individual prognosis and treatment of metastatic long bone lesions Oybek Abdusattorov (UZ) |
| 11:10–11:20 | Prognostic significance of the CHEK2 gene 1100DELC mutation in breast cancer development in women of Uzbekistan Guzal Asrorova (UZ) |
| 11:20–11:30 | Comparative analysis of histological and immunohistochemical characteristics of ependymomas in children and adults Nodira Raximova (UZ) |
| 11:30–11:40 | Treatment of soft tissue sarcomas with high-dose ifosfamide: National Oncology Center experience Debora Usubalieva (KG) |
| 11:40–11:50 | First experience of using the Revo-I robotic system in a multidisciplinary private clinic in Central Asia Azamat Rustamov (UZ) |
| 11:50–12:00 | Selective intra-arterial chemotherapy for eyeball preservation in retinoblastoma patients Farruh Mahmudov (UZ) |
| 12:00–12:10 | Optimization of surgical interventions in rectal cancer: single-stage feasibility Farxodjon Soliyev (UZ) |
| 12:10–12:20 | Contemporary approaches to surgical treatment of pelvic bone tumors Shirin Sulton (UZ) |
| 12:20–12:30 | Autologous fat tissue transplantation for post-radiation skin fibrosis in breast cancer patients Salva Dallo (UZ) |
| 12:30–12:40 | Breast cancer coexisting with thyroid cancer — correlation of IHC profiles and molecular-genetic analysis Gunel Musayeva (AZ) |
| 12:40–12:50 | Role of molecular markers in systemic therapy selection for metastatic colorectal cancer Maryam Ubaydullaeva (UZ) |
| 12:50–13:00 | A novel approach to multimodal treatment of cardioesophageal junction cancer Avazbek Umirov (UZ) |
| Lunch 13:00 – 14:00 | |
| 14:00–14:10 | Hormonal imbalance as pathogenetic basis of precancerous breast diseases in Karakalpakstan Umida Tursymuratova (UZ) |
| 14:10–14:20 | Improvement of technical and tactical aspects of colorectal cancer treatment using videolaparoscopic technologies Kamronshoh Komiljonov (UZ) |
| 14:20–14:30 | Radioligand therapy with Lu-177 PSMA in metastatic prostate cancer patients Sardorbek Sobitov (UZ) |
| 14:30–14:40 | Transarterial chemoembolization of hepatocellular carcinoma Nicat Alişov (AZ) |
| 14:40–14:50 | Efficacy of TRAM flap following radical mastectomy in breast cancer patients Zarifa Murodova (UZ) |
| 14:50–15:00 | Clinically significant risk groups and hidden phenotypes in lung cancer patients based on ML model Zeynep Avizova (KZ) |
| 15:00–15:10 | Assessment of risk factors and genetic predispositions in hereditary breast cancer Sevara Alimbayeva (UZ) |
| 15:10–15:20 | Surgical treatment of non-organ retroperitoneal tumors Kanibek Abdurasulov (KG) |
| 15:20–15:30 | Identifying determinants of delayed diagnosis and treatment of cervical cancer Gulnora Mamadiyeva (UZ) |
| 15:30–15:40 | Precision optimization of radiotherapy planning for head and neck tumors Saidjon Xasanboev (UZ) |
| 15:40–15:50 | Early cardio-oncological risk stratification in children receiving anthracycline therapy Sibel Rizaeva (UZ) |
| 15:50–16:00 | Microsurgical treatment of post-mastectomy lymphedema via LVA surgery Avaz Ismailov (UZ) |
| 16:00–16:10 | Frequency and clinical significance of ESR1 mutations in ER+/Her2- metastatic breast cancer Asror Xayriyev (UZ) |
| 16:10–16:20 | Retrospective study of cardiotoxicity in prostate cancer patients Kamola Maxmudova (UZ) |
| 16:20–16:30 | Comparative analysis of surgical methods for locally advanced gastric cancer Abbos Abduqodirov (UZ) |
| 16:30–16:40 | Radiation therapy for recurrent head and neck cancer Jurabek Kuvvtaov (UZ) |
| 16:40–16:50 | Specialized amino acids in optimizing intensive care for lung cancer chemotherapy complications Nuriddin Ergashev (UZ) |
| 16:50–17:00 | Post-radiation angiosarcoma of the breast — clinical case Gulcan Isakzade (AZ) |
| 08:30–08:50 |
Perioperative treatment approach
Gunel Musayeva (National Oncology Centre, Baku, Azerbaijan)
|
| 08:50–09:10 |
Modern technologies in minimally invasive gastric cancer surgery
Akzhol Dyusembaev (KazORIR, Almaty, Kazakhstan)
|
| 09:10–09:30 |
Surgical approach for oesophageal cancer
Abror Yusupbekov (Uzbekistan Oncology & Radiology Centre, Tashkent)
|
| 09:30–10:10 |
MDT
Oesophagogastric and pancreaticobiliary case discussion
Case presenter: Leyla Sert (Dicle University, Diyarbakir)
Samire Qaraisayeva (AZ) · Ramazan Esen (TR) · Mevlude Inanc (TR) · Dilshod Egamberdiev (UZ) · Akzhol Dyusembaev (KZ) · Manuchehr Safarov (KG) · Soleh Bokiev (TJ)
|
| 10:30–10:45 |
Total neoadjuvant therapy (medical oncology perspective)
Bulent Erdogan (Trakya University, Edirne, Turkiye)
|
| 10:45–11:00 |
Total neoadjuvant therapy (radiation oncology perspective)
Gunel Hacı (National Oncology Centre, Baku, Azerbaijan)
|
| 11:00–11:15 |
Total neoadjuvant therapy (surgical perspective)
Said Luqmanov (Uzbekistan Oncology & Radiology Centre, Tashkent)
|
| 11:15–12:00 |
MDT
Case discussion
Case presenter: Tayyip Ilker Aydin (Trakya University, Edirne)
Yusif Əliyarov (AZ) · Ummugul Uyeturk (TR) · Hurshid Islamov (UZ) · Shavkat Adilov (UZ) · Manuchehr Safarov (KG) · Soleh Bokiev (TJ)
|
| 13:30–13:45 |
Systemic treatment of metastatic oesophagogastric cancers
Nuriye Ozdemir (Gazi University, Ankara, Turkiye)
|
| 13:45–14:00 |
Surgical approach to liver metastases in lower GI tumours
Nauryzbay Imanbayev (West Kazakhstan Medical University, Almaty)
|
| 14:00–14:15 |
Combined treatment of locally advanced gastric cancer
Mirjalol Juraev (Uzbekistan, Tashkent)
|
| 14:15–14:30 |
Systemic treatment of advanced pancreaticobiliary cancers
Fatih Karatas (Karabuk University, Karabuk, Turkiye)
|
| 14:30–14:45 |
ERAS protocol in elderly and advanced-age colorectal cancer patients
Faridun Sattorov (Republican Oncology Centre, Dushanbe, Tajikistan)
|
| 15:00–15:15 |
Systemic treatment of metastatic head and neck cancers
Muhammet Bekir Hacioglu (Trakya University, Edirne, Turkiye)
|
| 15:15–15:30 |
Radiotherapy in head and neck cancers
Ainur Zhassaralova (KazORIR, Almaty, Kazakhstan)
|
| 15:30–15:45 |
Aspects of surgical intervention for oral cancer
Barot Zarobiddin (Republican Oncology Centre, Dushanbe, Tajikistan)
|
| 15:45–16:00 |
Factors affecting treatment outcomes of malignant epithelial salivary gland tumours
Amangeldi Zhumabaev (National Oncology & Haematology Centre, Bishkek, Kyrgyzstan)
|
| 16:00–16:10 |
Improving surgical and pathogenetic treatment of differentiated thyroid cancer
Muzaffar Malikov (Uzbekistan Oncology & Radiology Centre, Tashkent)
|
| 16:10–16:20 |
Tongue cancer: modern approaches to surgical treatment and reconstruction
Aziz Kubaev (Samarkand State Medical University, Uzbekistan)
|
| 16:20–16:50 |
MDT
Locally advanced head and neck cancer — case presentation
Ahmet Siyar Ekinci (Memorial Diyarbakir, Turkiye)
|
| 17:00–17:15 |
Systemic treatment of soft-tissue sarcomas
Meltem Ekenel (Istanbul University, Istanbul, Turkiye)
|
| 17:15–17:30 |
Soft-tissue sarcoma surgery
Tamara Guliyeva (Azerbaijan Medical University, Baku)
|
| 17:30–17:45 |
Radiotherapy in sarcomas
Kamshat Kuatzhanova (KazORIR, Almaty, Kazakhstan)
|
| 08:30–08:45 |
Treatment management in metastatic cervical cancer
Hatice Odabas (Kartal Lutfi Kirdar City Hospital, Istanbul, Turkiye)
|
| 08:45–09:00 |
Surgical approach in early-stage endometrial cancer
Shamistan Aliyev (National Oncology Centre, Baku, Azerbaijan)
|
| 09:00–09:15 |
Radiotherapy and 3D brachytherapy in endometrial and cervical cancer
Anar Kurmanova (KazORIR, Almaty, Kazakhstan)
|
| 09:15–09:30 |
Importance of screening and vaccination in cervical cancer
Nargiza Zakhirova (Uzbekistan Oncology & Radiology Centre, Tashkent)
|
| 09:30–10:10 |
MDT
Case discussion
Case presenter: Nilgun Yildirim (Elazig Medikal Hospital)
Turkan Mansurova (AZ) · Dogan Yazilitas (TR) · Odil Akhmedov (UZ) · Alima Satanova (KZ)
|
| 10:30–10:45 |
Timing of surgery in ovarian cancer
Alima Satanova (KazORIR, Almaty, Kazakhstan)
|
| 10:45–11:00 |
Current developments in systemic treatment of ovarian cancer
Elvina Almuradova (Memorial Goztepe, Istanbul, Turkiye)
|
| 11:00–11:15 |
Current developments in systemic treatment of endometrial cancer
Elxan Kazimov (National Oncology Centre, Baku, Azerbaijan)
|
| 11:15–12:00 |
MDT
Case discussion
Case presenter: Hamza Abbasov (Medicalpark Istinye Univ. GOP Hospital, Istanbul)
Nigar Aliyeva (AZ) · Ozkan Alan (TR) · Kamila Izrailbekova (UZ) · Anar Kurmanova (KZ)
|
| 13:30–13:50 |
Current developments — metastatic castration-resistant disease
Okan Avci (Tekirdag Namik Kemal University, Turkiye)
|
| 13:50–14:10 |
Role of surgery in prostate cancer
Elnur Mirzeyev (National Oncology Centre, Baku, Azerbaijan)
|
| 14:10–14:30 |
Role of radiotherapy in prostate cancer
Shapagat Myngzhassarova (KazORIR, Almaty, Kazakhstan)
|
| 14:30–14:50 |
Current developments — metastatic castration-sensitive disease
Huseyin Salih Semiz (Dokuz Eylul University, Izmir, Turkiye)
|
| 15:10–15:25 |
Systemic treatment of metastatic renal cancer
Tolga Koseci (Cukurova University, Adana, Turkiye)
|
| 15:25–15:40 |
Surgical management of renal cancers with thrombosis
Oybek Khalmurzaev (Uzbekistan Oncology & Radiology Centre, Tashkent)
|
| 15:40–15:55 |
Role of surgery in bladder cancer
Khusan Umurzakov (KazORIR, Almaty, Kazakhstan)
|
| 15:55–16:10 |
Bladder cancer epidemiology in Kyrgyzstan
Emil Makimbetov (Kyrgyz-Russian Slavic University, Bishkek)
|
| 16:10–16:25 |
Systemic treatment of bladder cancer
Kamila Izrailbekova (Uzbekistan Oncology & Radiology Centre, Tashkent)
|